BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24061483)

  • 1. NRG3 gene is associated with the risk and age at onset of Alzheimer disease.
    Wang KS; Xu N; Wang L; Aragon L; Ciubuc R; Arana TB; Mao C; Petty L; Briones D; Su BB; Luo X; Camarillo C; Escamilla MA; Xu C
    J Neural Transm (Vienna); 2014 Feb; 121(2):183-92. PubMed ID: 24061483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease.
    Wang KS; Liu Y; Xu C; Liu X; Luo X
    J Neuroimmunol; 2017 Sep; 310():60-65. PubMed ID: 28778446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol.
    Chen Y; Xu C; Harirforoosh S; Luo X; Wang KS
    J Psychiatr Res; 2018 Jan; 96():65-72. PubMed ID: 28987514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.
    Kao WT; Wang Y; Kleinman JE; Lipska BK; Hyde TM; Weinberger DR; Law AJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15619-24. PubMed ID: 20713722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer's disease.
    Wang KS; Tonarelli S; Luo X; Wang L; Su B; Zuo L; Mao C; Rubin L; Briones D; Xu C
    J Neural Transm (Vienna); 2015 May; 122(5):701-8. PubMed ID: 25410587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
    Kamboh MI; Minster RL; Feingold E; DeKosky ST
    Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
    Naj AC; Jun G; Reitz C; Kunkle BW; Perry W; Park YS; Beecham GW; Rajbhandary RA; Hamilton-Nelson KL; Wang LS; Kauwe JS; Huentelman MJ; Myers AJ; Bird TD; Boeve BF; Baldwin CT; Jarvik GP; Crane PK; Rogaeva E; Barmada MM; Demirci FY; Cruchaga C; Kramer PL; Ertekin-Taner N; Hardy J; Graff-Radford NR; Green RC; Larson EB; St George-Hyslop PH; Buxbaum JD; Evans DA; Schneider JA; Lunetta KL; Kamboh MI; Saykin AJ; Reiman EM; De Jager PL; Bennett DA; Morris JC; Montine TJ; Goate AM; Blacker D; Tsuang DW; Hakonarson H; Kukull WA; Foroud TM; Martin ER; Haines JL; Mayeux RP; Farrer LA; Schellenberg GD; Pericak-Vance MA; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barnes LL; Beach TG; Becker JT; Beekly D; Bigio EH; Bowen JD; Boxer A; Burke JR; Cairns NJ; Cantwell LB; Cao C; Carlson CS; Carney RM; Carrasquillo MM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Dick M; Dickson DW; Duara R; Faber KM; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Growdon JH; Hamilton RL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jicha GA; Jin LW; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lin CF; Lopez OL; Lyketsos CG; Mack WJ; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Murrell JR; Olichney JM; Pankratz VS; Parisi JE; Paulson HL; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reisberg B; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Valladares O; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
    JAMA Neurol; 2014 Nov; 71(11):1394-404. PubMed ID: 25199842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data.
    Saad M; Brkanac Z; Wijsman EM
    Genes Brain Behav; 2015 Nov; 14(8):607-17. PubMed ID: 26394601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.
    Turner JR; Ray R; Lee B; Everett L; Xiang J; Jepson C; Kaestner KH; Lerman C; Blendy JA
    Mol Psychiatry; 2014 Jul; 19(7):801-10. PubMed ID: 23999525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer's Disease.
    Wang KS; Liu X; Xie C; Liu Y; Xu C
    J Mol Neurosci; 2016 Dec; 60(4):436-444. PubMed ID: 27586004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease.
    Capurso C; Panza F; Seripa D; Frisardi V; Imbimbo BP; Verdile G; Vendemiale G; Pilotto A; Solfrizzi V
    Rejuvenation Res; 2010 Dec; 13(6):645-52. PubMed ID: 20818931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community.
    Ma SL; Tang NL; Tam CW; Lui VW; Lau ES; Zhang YP; Chiu HF; Lam LC
    Int Psychogeriatr; 2009 Oct; 21(5):977-86. PubMed ID: 19586561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association analysis of age-at-onset in Alzheimer's disease.
    Kamboh MI; Barmada MM; Demirci FY; Minster RL; Carrasquillo MM; Pankratz VS; Younkin SG; Saykin AJ; ; Sweet RA; Feingold E; DeKosky ST; Lopez OL
    Mol Psychiatry; 2012 Dec; 17(12):1340-6. PubMed ID: 22005931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
    Ozturk A; DeKosky ST; Kamboh MI
    Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population.
    Kara HG; Erdal ME; Yılmaz SG; Şengül C; Şengül CB; Karakülah K
    Mol Biol Rep; 2021 Jun; 48(6):5319-5326. PubMed ID: 34247340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MxA polymorphisms are associated with risk and age-at-onset in Alzheimer disease and accelerated cognitive decline in Chinese elders.
    Ma SL; Huang W; Tang NL; Lam LC
    Rejuvenation Res; 2012 Oct; 15(5):516-22. PubMed ID: 22950423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
    Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
    Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
    Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST
    Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
    Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
    Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition.
    Morar B; Dragović M; Waters FA; Chandler D; Kalaydjieva L; Jablensky A
    Mol Psychiatry; 2011 Aug; 16(8):860-6. PubMed ID: 20548296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.